Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125704681 | 12570468 | 1 | I | 201511 | 20160617 | 20160719 | 20160719 | EXP | GB-TEVA-670384ACC | TEVA | 50.50 | YR | F | Y | 0.00000 | 20160719 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125704681 | 12570468 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MILLIGRAM DAILY; | U | UNKNOWN | 77232 | 20 | MG | FILM-COATED TABLET | QD | ||||
| 125704681 | 12570468 | 2 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | U | UNKNOWN | 77232 | 10 | MG | ||||||||
| 125704681 | 12570468 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125704681 | 12570468 | 1 | Anxiety |
| 125704681 | 12570468 | 3 | Abdominal pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125704681 | 12570468 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125704681 | 12570468 | Abdominal pain upper | |
| 125704681 | 12570468 | Cerebral haemorrhage | |
| 125704681 | 12570468 | Cerebrovascular accident | |
| 125704681 | 12570468 | Head injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |